Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Epilepsy D004827 35 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Birth Weight D001724 23 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Nasal Polyps D009298 26 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Ear Diseases D004427 7 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Agranulocytosis D000380 7 associated lipids
Shock D012769 11 associated lipids
Polycythemia Vera D011087 13 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Ventricular Fibrillation D014693 16 associated lipids
Fever D005334 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Spasm D001986 18 associated lipids
Shock, Septic D012772 11 associated lipids
Immune Complex Diseases D007105 9 associated lipids
Conjunctivitis D003231 7 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Death, Sudden D003645 12 associated lipids
Vitamin E Deficiency D014811 29 associated lipids
Cardiomegaly D006332 31 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Neutropenia D009503 15 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Meningioma D008579 11 associated lipids
Multiple Trauma D009104 2 associated lipids
Cluster Headache D003027 4 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Behcet Syndrome D001528 7 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Migraine Disorders D008881 11 associated lipids
Malabsorption Syndromes D008286 16 associated lipids
Pregnancy Complications, Cardiovascular D011249 11 associated lipids
Thrombasthenia D013915 4 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Shock, Traumatic D012774 4 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Arthus Reaction D001183 8 associated lipids
Thrombocytosis D013922 4 associated lipids
Toxemia D014115 3 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Klebsiella Infections D007710 7 associated lipids
Ascites D001201 25 associated lipids
Albuminuria D000419 18 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Hyperinsulinism D006946 27 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Parkinson Disease D010300 53 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Bronchial Diseases D001982 3 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Tangier Disease D013631 8 associated lipids
Heart Arrest D006323 13 associated lipids
Cystitis D003556 23 associated lipids
Cholecystitis D002764 8 associated lipids
HIV Infections D015658 20 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Medulloblastoma D008527 22 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Hypertension, Portal D006975 12 associated lipids
Atherosclerosis D050197 85 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Dyslexia D004410 3 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Partrick DA et al. Hypertonic saline activates lipid-primed human neutrophils for enhanced elastase release. 1998 J Trauma pmid:9555828
Cherniad'eva IF et al. [Characteristics of development of oxidative stress in blood plasma of patients with familial hypercholesterolemia]. 1998 Biull Eksp Biol Med pmid:9559141
Lallès JP et al. Small intestinal motility disorders in preruminant calves chronically fed a diet based on antigenic soya: characterization and possible mediators. 1998 Jan-Feb Vet. Res. pmid:9559521
Michibayashi T Neurogenic inhibitory action through platelets of platelet activating factor (PAF) on vasoconstrictive responsiveness to pressor agents. 1997 Adv. Exp. Med. Biol. pmid:9561145
Ishii I et al. High and low affinity mutants of platelet-activating factor receptor. 1997 Adv. Exp. Med. Biol. pmid:9561146
Heller A et al. Lipid mediators in inflammatory disorders. 1998 Drugs pmid:9561339
Wei Y et al. Structure of a microbial homologue of mammalian platelet-activating factor acetylhydrolases: Streptomyces exfoliatus lipase at 1.9 A resolution. 1998 Structure pmid:9562561
Akiyama M et al. Identification of a major PAF acetylhydrolase in human serum/plasma as a 43 kDa glycoprotein containing about 9 kDa asparagine-conjugated sugar chain(s). 1998 J. Biochem. pmid:9562606
da Silva MB et al. Effect of ketoprofen on PAF-induced bovine platelet aggregation. 1998 Vet. J. pmid:9564275
Brunet J et al. In vitro antioxidant properties of calcium dobesilate. 1998 Fundam Clin Pharmacol pmid:9565776
Ezeamuzie CI et al. The effect of salmeterol on human eosinophils is both stimulus- and response-dependent. 1997 Int. J. Immunopharmacol. pmid:9568547
Ruiz-Ortega M et al. Overexpression of extracellular matrix proteins in renal tubulointerstitial cells by platelet-activating-factor stimulation. 1998 Nephrol. Dial. Transplant. pmid:9568845
Snapper JR et al. Effect of platelet-activating factor-receptor antagonism on endotoxin-induced lung dysfunction in sheep. 1998 J. Appl. Physiol. pmid:9572806
Cines DB et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. 1998 Blood pmid:9572988
Thijs A and Thijs LG Pathogenesis of renal failure in sepsis. 1998 Kidney Int. Suppl. pmid:9573570
Kitayama J et al. The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow. 1998 J. Clin. Invest. pmid:9576767
Shindo K and Fukumura M Oxatomide inhibits synthesis and release of platelet-activating factor in human neutrophils. 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9578146
Ereth MH et al. The relation between the platelet-activated clotting test (HemoSTATUS) and blood loss after cardiopulmonary bypass. 1998 Anesthesiology pmid:9579505
Hüseyinov A et al. Plasma and urinary platelet activating factor concentrations and leukotriene releasing activity of leukocytes in steroid sensitive nephrotic syndrome of childhood. 1998 Acta Paediatr Jpn pmid:9583202
Takasaki J et al. Synergistic effect of type II phospholipase A2 and platelet-activating factor on Mac-1 surface expression and exocytosis of gelatinase granules in human neutrophils: evidence for the 5-lipoxygenase-dependent mechanism. 1998 J. Immunol. pmid:9590257
Pietsch P et al. Effects of platelet-activating factor on intracellular Ca2+ concentration and contractility in isolated cardiomyocytes. 1998 J. Cardiovasc. Pharmacol. pmid:9593076
Jackson JR et al. The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis. 1998 Biochim. Biophys. Acta pmid:9593866
Colak O et al. The effect of Ginkgo biloba on the activity of catalase and lipid peroxidation in experimental strangulation ileus. 1998 Int. J. Clin. Lab. Res. pmid:9594365
Wang F et al. [The effect of platelet activating factor on the biosynthesis of thromboxane A2 and prostaglandin I2 in human placental villi and umbilical artery]. 1997 Zhonghua Fu Chan Ke Za Zhi pmid:9596897
Yamada M et al. Inhibition of tumor necrosis factor-alpha production by SK&F 98625, a CoA-independent transacylase inhibitor, in cultured rat peritoneal macrophages. 1998 Life Sci. pmid:9600332
Lie WJ et al. Degranulation of human basophils by picomolar concentrations of IL-3, IL-5, or granulocyte-macrophage colony-stimulating factor. 1998 J. Allergy Clin. Immunol. pmid:9600507
Giménez R and Aguilar J Effects of CDP-choline administration on brain striatum platelet-activating factor in aging rats. 1998 Eur. J. Pharmacol. pmid:9600649
László F and Whittle BJ Role of nitric oxide and platelet-activating factor in the initiation of indomethacin-provoked intestinal inflammation in rats. 1998 Eur. J. Pharmacol. pmid:9600654
Gómez FP et al. The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma. 1998 Am. J. Respir. Crit. Care Med. pmid:9603138
O'Neill C Autocrine mediators are required to act on the embryo by the 2-cell stage to promote normal development and survival of mouse preimplantation embryos in vitro. 1998 Biol. Reprod. pmid:9603268
Kotelevets L et al. Inhibition by platelet-activating factor of Src- and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3'-kinase is a critical mediator of tumor invasion. 1998 J. Biol. Chem. pmid:9603913
ZaÄ­tseva LG et al. [The role of platelet activating factor in regulation of the phagocytic function of macrophages from different organs]. 1998 Biull Eksp Biol Med pmid:9606554
Nguyen P et al. [Modulators of leukocytic functions]. 1998 J Mal Vasc pmid:9608925
Nakos G et al. Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components. 1998 Intensive Care Med pmid:9609406
Tsuji F and Shirasawa E The role of platelet-activating factor in cell infiltration in endotoxin-induced uveitis in guinea pigs. 1998 Curr. Eye Res. pmid:9617545
Shimada A et al. In situ expression of platelet-activating factor (PAF)-receptor gene in rat skin and effects of PAF on proliferation and differentiation of cultured human keratinocytes. 1998 J. Invest. Dermatol. pmid:9620295
Mollinedo F et al. Physiological activation of human neutrophils down-regulates CD53 cell surface antigen. 1998 J. Leukoc. Biol. pmid:9620662
Lou YP et al. Platelet-activating factor induces goblet cell hyperplasia and mucin gene expression in airways. 1998 Am. J. Respir. Crit. Care Med. pmid:9620929
Lapchyns'ka II [Platelet activating factor and its role in the pathogenesis of immune glomerulopathy]. 1998 Jan-Feb Lik. Sprava pmid:9621619
Isumi H et al. Expression of a 45K subunit of platelet-activating factor acetylhydrolase in the developing mouse cerebellum. 1998 Anat. Embryol. pmid:9623676
Gómez FP et al. Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma. 1998 Eur. Respir. J. pmid:9623685
Werr J et al. beta1 integrins are critically involved in neutrophil locomotion in extravascular tissue In vivo. 1998 J. Exp. Med. pmid:9625769
Takada Y et al. Prolonged hepatic warm ischemia in non-heart-beating donors: protective effects of FK506 and a platelet activating factor antagonist in porcine liver transplantation. 1998 Surgery pmid:9626320
Spapen H et al. The platelet-activating factor antagonist BB-882 does not improve tissue oxygen extraction in endotoxic shock. 1998 J Crit Care pmid:9627275
De Plaen IG et al. Intestinal NF-kappaB is activated, mainly as p50 homodimers, by platelet-activating factor. 1998 Biochim. Biophys. Acta pmid:9630621
Baker RR and Chang H MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities. 1998 Biochim. Biophys. Acta pmid:9630721
Beck-Speier I et al. Pro-inflammatory response of alveolar macrophages induced by sulphite: studies with lucigenin-dependent chemiluminescence. 1998 Mar-Apr J. Biolumin. Chemilumin. pmid:9633012
Grassi S et al. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei. 1998 J. Neurophysiol. pmid:9636125
Izuoka T et al. Role of platelet-activating factor on extravascular lung water after coronary reperfusion in dogs. 1998 Jpn. J. Physiol. pmid:9639551
Mackness B et al. Lack of protection against oxidative modification of LDL by avian HDL. 1998 Biochem. Biophys. Res. Commun. pmid:9642147
Botitsi E et al. Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells. 1998 J. Lipid Res. pmid:9643362
Jung KY et al. Magnone A and B, novel anti-PAF tetrahydrofuran lignans from the flower buds of Magnolia fargesii. 1998 J. Nat. Prod. pmid:9644071
Derewenda ZS and Derewenda U The structure and function of platelet-activating factor acetylhydrolases. 1998 Cell. Mol. Life Sci. pmid:9645224
Shouji K et al. Platelet-activating factor is a key mediator of pulmonary vasoconstriction and bronchoconstriction after antigen challenge in the perfused sensitized rabbit lung. 1998 Shock pmid:9645492
Qayumi AK et al. The role of platelet-activating factor in regional myocardial ischemia-reperfusion injury. 1998 Ann. Thorac. Surg. pmid:9647083
Watson F and Edwards SW Stimulation of primed neutrophils by soluble immune complexes: priming leads to enhanced intracellular Ca2+ elevations, activation of phospholipase D, and activation of the NADPH oxidase. 1998 Biochem. Biophys. Res. Commun. pmid:9647777
Matsumoto K et al. Proinflammatory cytokine-induced and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase-dependent pathway. 1998 J. Allergy Clin. Immunol. pmid:9648711
Shindo K et al. Platelet-activating factor increases leukotriene B4 release in stimulated alveolar macrophages from asthmatic patients. 1998 Eur. Respir. J. pmid:9648962
Han BH et al. In vitro platelet-activating factor receptor binding inhibitory activity of pinusolide derivatives: a structure-activity study. 1998 J. Med. Chem. pmid:9651167
Minamiya Y et al. Platelet-activating factor mediates intercellular adhesion molecule-1-dependent radical production in the nonhypoxic ischemia rat lung. 1998 Am. J. Respir. Cell Mol. Biol. pmid:9651191
Perry SW et al. Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis. 1998 J. Biol. Chem. pmid:9651362
Roudebush WE and Mathur RS Presence of platelet-activating factor in squirrel monkey (Saimiri boliviensis) spermatozoa: seasonal differences. 1998 Am. J. Primatol. pmid:9651652
Küçükhüseyin C et al. On the mechanisms of adenosine induced pulmonary vasoconstriction in rats. 1997 J Basic Clin Physiol Pharmacol pmid:9651801
Ginkgo biloba for dementia. 1998 Med Lett Drugs Ther pmid:9653424
Itadani K et al. Inhibition of Na+,K(+)-ATPase by platelet-activating factor in dog submandibular glands. 1998 Prostaglandins Other Lipid Mediat. pmid:9653774
Loucks EB et al. Platelet-activating factor antagonism: a new concept in the management of regional myocardial ischemia-reperfusion injury. 1997 Nov-Dec J Invest Surg pmid:9654389
Schwartz JD et al. Cardiopulmonary bypass primes polymorphonuclear leukocytes. 1998 J. Surg. Res. pmid:9655092
Rainger GE et al. Neutrophils rolling on immobilised platelets migrate into homotypic aggregates after activation. 1998 Thromb. Haemost. pmid:9657445
Ahmed A et al. Localization, quantification, and activation of platelet-activating factor receptor in human endometrium during the menstrual cycle: PAF stimulates NO, VEGF, and FAKpp125. 1998 FASEB J. pmid:9657523
Akisü M et al. Effect of dietary n-3 fatty acids on hypoxia-induced necrotizing enterocolitis in young mice. n-3 fatty acids alter platelet-activating factor and leukotriene B4 production in the intestine. 1998 Biol. Neonate pmid:9657667
Manya H et al. Switching of platelet-activating factor acetylhydrolase catalytic subunits in developing rat brain. 1998 J. Biol. Chem. pmid:9660828
Tuder RM and Voelkel NF Pulmonary hypertension and inflammation. 1998 J. Lab. Clin. Med. pmid:9665367
Barber LA et al. Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. 1998 J. Biol. Chem. pmid:9668065
Peçanha EP et al. Synthesis and pharmacological evaluation of a new class of bicyclic phospholipids, designed as platelet activating factor antagonists. 1998 Farmaco pmid:9679282
da Silva MB et al. Protective effects of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced changes in the morphological ultrastructure of blood platelets in calves. 1998 Vet. Res. Commun. pmid:9686442
Bussolati B et al. Platelet-activating factor synthesized by IL-12-stimulated polymorphonuclear neutrophils and NK cells mediates chemotaxis. 1998 J. Immunol. pmid:9686616
Gozal D et al. Platelet-activating factor modulates cardiorespiratory responses in the conscious rat. 1998 Am. J. Physiol. pmid:9688699
Stolarek R et al. Effect of various agonists on nitric oxide generation by human polymorphonuclear leukocytes. 1998 Int. J. Clin. Lab. Res. pmid:9689552
Ribaldi E et al. PAF levels in saliva are regulated by inflammatory cells. 1998 J. Periodont. Res. pmid:9689619
Kaminskaia GO et al. [Features of oxidative metabolism and level of platelet activating factor in pulmonary and circulating phagocytes of tuberculosis-resistant animals at stages of experimental infection]. 1998 Probl Tuberk pmid:9691697
Li HP et al. Effect of chinonin on acute hypoxic pulmonary vasoconstriction in Sprague-Dawley rats. 1998 Respirology pmid:9692515
Moro F et al. The beta and gamma subunits of the human platelet-activating factor acetyl hydrolase isoform Ib (PAFAH1B2 and PAFAH1B3) map to chromosome 11q23 and 19q13.1, respectively. 1998 Genomics pmid:9693049
Napoli C Familial hypercholesterolaemia and platelet-activating factor acetylhydrolase: difference between the homozygous and heterozygous form. 1998 Eur. J. Clin. Invest. pmid:9693945
Karlsson H et al. Heparin ameliorates pulmonary hypertension induced by platelet-activating factor in pigs. 1998 Thromb. Res. pmid:9694244
Eakes AT and Olson MS Regulation of endothelin synthesis in hepatic endothelial cells. 1998 Am. J. Physiol. pmid:9696707
Cruzado JM et al. Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model. 1998 Clin. Exp. Immunol. pmid:9697996
DeCoster MA et al. Platelet-activating factor is a downstream messenger of kainate-induced activation of mitogen-activated protein kinases in primary hippocampal neurons. 1998 J. Neurosci. Res. pmid:9698157
Alves AC et al. Effect of selective phosphodiesterase inhibitors on the rat eosinophil chemotactic response in vitro. 1997 Mem. Inst. Oswaldo Cruz pmid:9698934
Koyama S et al. Human lung fibroblasts release chemokinetic activity for monocytes constitutively. 1998 Am. J. Physiol. pmid:9700081
Andersson R et al. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats. 1998 Pancreas pmid:9700940
Pennings HJ et al. Tumour necrosis factor-alpha induces hyperreactivity in tracheal smooth muscle of the guinea-pig in vitro. 1998 Eur. Respir. J. pmid:9701413
Akisü M et al. Platelet-activating factor levels in term and preterm human milk. 1998 Biol. Neonate pmid:9701651
Thakur A and Willcox MD Cytokine and lipid inflammatory mediator profile of human tears during contact lens associated inflammatory diseases. 1998 Exp. Eye Res. pmid:9702174
Boulay F et al. Phagocyte chemoattractant receptors. 1997 Ann. N. Y. Acad. Sci. pmid:9704038
Pérez-Arellano JL et al. BN 52021 (a platelet activating factor-receptor antagonist) decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis. 1998 Mediators Inflamm. pmid:9705608
Pei Y et al. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. 1998 J. Immunol. pmid:9712066
Hilliquin P et al. A double blind, placebo controlled study of a platelet activating factor antagonist in patients with rheumatoid arthritis. 1998 J. Rheumatol. pmid:9712091
Tamaoki J et al. A human bronchial epithelial cell line releases arginine vasopressin: involvement of Ca2+ -activated K+ channels. 1998 Regul. Pept. pmid:9712168
Tsai IL et al. Anti-platelet aggregation constituents from Formosan Toddalia asiatica. 1998 Phytochemistry pmid:9720317
Karzai W et al. [Current aspects of immunomodulatory therapy initiation for sepsis]. 1998 Dtsch. Med. Wochenschr. pmid:9721572